Cited by

• Cost-effectiveness of the ONCORAL multidisciplinary programme for the management of outpatients taking oral anticancer agents at risk of drug-related event: protocol for a pragmatic randomised controlled study.

  Huot L, Guerre P, Descotes G, Caffin AG, Herledan C, Ranchon F, Rioufol C. Huot L, et al. BMJ Open. 2024 Feb 17;14(2):e074956. doi: 10.1136/bmjopen-2023-074956. BMJ Open. 2024. PMID: 38367968 Free PMC article.
• Cotargeting Phosphoinositide 3-Kinase and Focal Adhesion Kinase Pathways Inhibits Proliferation of NF2 Schwannoma Cells.

  Hardin HM, Dinh CT, Huegel J, Petrilli AM, Bracho O, Allaf AM, Karajannis MA, Griswold AJ, Ivan ME, Morcos J, Gultekin SH, Telischi FF, Liu XZ, Fernandez-Valle C. Hardin HM, et al. Mol Cancer Ther. 2023 Nov 1;22(11):1280-1289. doi: 10.1158/1535-7163.MCT-23-0135. Mol Cancer Ther. 2023. PMID: 37527526
• How Can the Microbiome Induce Carcinogenesis and Modulate Drug Resistance in Cancer Therapy?

  Mendes I, Vale N. Mendes I, et al. Int J Mol Sci. 2023 Jul 24;24(14):11855. doi: 10.3390/ijms241411855. Int J Mol Sci. 2023. PMID: 37511612 Free PMC article. Review.
• Ferroptosis and its emerging role in tumor.

  Wang X, Liu Z, Ma L, Yu H. Wang X, et al. Biophys Rep. 2021 Aug 31;7(4):280-294. doi: 10.52601/bpr.2021.210010. Biophys Rep. 2021. PMID: 37287758 Free PMC article.
• Feasibility and Toxicity of Interval-Compressed Chemotherapy in Asian Children and Young Adults with Sarcoma.

  Huang JH, Chen SH, Liao YM, Kao YC, Ho WL, Chang H, Tsai ML, Lee HL, Kuo CC, Tseng SH, Chang CY, Hsieh KL, Lu LS, Chen YJ, Chiou JF, Hsieh TH, Liu YR, Hsu W, Li WT, Wu YC, Wu WC, Wang JL, Tsai JJ, Terashima K, Kiyotani C, Wong TT, Miser JS, Liu YL. Huang JH, et al. J Pers Med. 2023 Apr 14;13(4):668. doi: 10.3390/jpm13040668. J Pers Med. 2023. PMID: 37109054 Free PMC article.